MedTrace Logo

Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)

NCT01895634 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2016-03-07

Study results available
· View outcomes & findings →

Summary

The main objective of this study is to document that the thrombectomy catheter (Rev-01) is effective and safe when used for revascularization in subjects with acute ischemic stroke within 8 hours of symptom onset who are ineligible for treatment with IV t-PA, or in whom treatment with IV t-PA has been ineffective.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

Rev-01

Treatment arm patients have used Rev-01 at least once

Sponsors & Collaborators

  • Johnson & Johnson K.K. Medical Company

    lead INDUSTRY

Principal Investigators

  • Nobuyuki Sakai, M.D., D.M.Sc · Kobe City Medical Center General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01895634 on ClinicalTrials.gov